Friday 6 November 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.

Revenue: +19.2%
EPS: +64.1%
Free cash flow: −29.8%
Total debt: −5.19%

Quarter to September 2026, against a year earlier

145.57 10.55 −6.76%

Follow PODD

Alert me

Market cap: $10.8B
P/E: 25.2×
Fwd P/E: 24.4×
Dividend yield: —
F-score: 6/9
Altman Z: 9.09
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Insulet Corporation 10-Q filed Nov 8, 2024

Fiscal Q3 2024 · Period ended Sep 30, 2024 · Filed Nov 8, 2024 · accepted 5:41 PM ET · Document on sec.gov · Filing index

Red flags

Material weakness Nov 8, 2024
Insulet Corporation’s 10-Q reports a material weakness in internal control over financial reporting

Management believes that these actions will remediate the material weakness; however, the material weakness will not be considered remediated until management has concluded that these controls are operating effectively.

10-Q filed Nov 8, 2024 · The filing · sec.gov